Literature DB >> 2170014

Localization of collagenase at the basal plasma membrane of a human pancreatic carcinoma cell line.

U M Moll1, B Lane, S Zucker, K Suzuki, H Nagase.   

Abstract

We have recently presented biochemical evidence for collagen and gelatin degrading activities associated with plasma membranes of various human cancer cell lines. In this report we describe the localization of interstitial collagenase at the basal plasma membrane of the human pancreatic cancer cell line RWP-I, using immunofluorescence and ultrastructural immunogold labeling techniques. Collagenase was expressed on the extracellular face of the plasma membrane. Furthermore, the immunogold labeling was concentrated on the long, finger-like microvillous projections typically seen on the basal cell surface, while the short, brush-like projections characteristic of the apical cell surface were unlabeled. When the cytoplasmic face of the membrane was made accessible, the number of reactive sites increased markedly, indicating a high concentration of enzyme at the inner surface of the plasma membrane. When plasma membrane fractions of RWP-I cells were prepared by differential centrifugation, high salt washes virtually failed to extract collagenase activity from the membrane, while detergent extraction with n-octyl glucoside, a detergent used in the purification of integral membrane proteins, yielded soluble collagenase activity. When detergent extracted membrane fractions were passed over an anticollagenase immunoaffinity column, collagenase was specifically bound, as demonstrated by the TCA and TCB degradation of type I collagen by the bound material. Gelatinolytic activity did not bind to the column. Furthermore, immunoprecipitation of 125I-labeled detergent extracts of tumor membranes yielded a single Mr 55,000 band consistent with the zymogen form of the connective tissue collagenase. These morphological and biochemical findings suggest that collagenase is a tightly associated component of the basal plasma membrane, where it occupies a strategic location for directional proteolysis during cell migration and invasion.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2170014

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

1.  Role of the 21-kDa protein TIMP-3 in oncogenic transformation of cultured chicken embryo fibroblasts.

Authors:  T T Yang; S P Hawkes
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

2.  Clinical impact of HAb18G/CD147 expression in esophageal squamous cell carcinoma.

Authors:  Shaojun Zhu; Yanhong Li; Li Mi; Yang Zhang; Li Zhang; Li Gong; Xiujuan Han; Li Yao; Miao Lan; Zhinan Chen; Wei Zhang
Journal:  Dig Dis Sci       Date:  2011-07-26       Impact factor: 3.199

Review 3.  The role of cell adhesion molecules and proteases in tumor invasion and metastasis.

Authors:  M J Bussemakers; J A Schalken
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

4.  Substituted Syndecan-2-Derived Mimetic Peptides Show Improved Antitumor Activity over the Parent Syndecan-2-Derived Peptide.

Authors:  Bohee Jang; Ayoung Kim; Yejin Lee; Jisun Hwang; Jee-Young Sung; Eun-Ju Jang; Yong-Nyun Kim; Ji-Hye Yun; Jeongmin Han; Ji-Joon Song; Weontae Lee; Eok-Soo Oh
Journal:  Int J Mol Sci       Date:  2022-05-24       Impact factor: 6.208

5.  Biochemical and immunohistochemical analysis of cathepsins B, H, L and D in human melanocytic tumours.

Authors:  T Kageshita; A Yoshii; T Kimura; K Maruo; T Ono; M Himeno; Y Nishimura
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

6.  Proteolysis of extracellular matrix by invadopodia facilitates human breast cancer cell invasion and is mediated by matrix metalloproteinases.

Authors:  T Kelly; Y Yan; R L Osborne; A B Athota; T L Rozypal; J C Colclasure; W S Chu
Journal:  Clin Exp Metastasis       Date:  1998-08       Impact factor: 5.150

7.  Expression of collagenase (MMP2), stromelysin (MMP3) and tissue inhibitor of the metalloproteinases (TIMP1) in pancreatic and ampullary disease.

Authors:  S R Bramhall; G W Stamp; J Dunn; N R Lemoine; J P Neoptolemos
Journal:  Br J Cancer       Date:  1996-04       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.